Meera Natarajan

Array ( [id] => 5189169 [patent_doc_number] => 20070167478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Biomarkers for sensitivity of proliferative diseases to mtor inhibitors' [patent_app_type] => utility [patent_app_number] => 10/583674 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2654 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167478.pdf [firstpage_image] =>[orig_patent_app_number] => 10583674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903675 [patent_doc_number] => 20130171178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Immunogenic Peptides of Xage-1' [patent_app_type] => utility [patent_app_number] => 10/582703 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18910 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10582703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 225051 [patent_doc_number] => 07605235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Anti-tissue factor antibodies and compositions' [patent_app_type] => utility [patent_app_number] => 11/010797 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 29498 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605235.pdf [firstpage_image] =>[orig_patent_app_number] => 11010797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966029 [patent_doc_number] => 20050232926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Antibodies specific for cancer associated antigen SM5-1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/004659 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23193 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232926.pdf [firstpage_image] =>[orig_patent_app_number] => 11004659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826635 [patent_doc_number] => 07402298 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-22 [patent_title] => 'EphA2 monoclonal antibodies and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 11/004005 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23136 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402298.pdf [firstpage_image] =>[orig_patent_app_number] => 11004005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210945 [patent_doc_number] => 20070249529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Compositions Comprising Polypeptides' [patent_app_type] => utility [patent_app_number] => 10/580660 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10067 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249529.pdf [firstpage_image] =>[orig_patent_app_number] => 10580660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5165283 [patent_doc_number] => 20070286867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Combination Therapy' [patent_app_type] => utility [patent_app_number] => 10/580662 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 16748 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286867.pdf [firstpage_image] =>[orig_patent_app_number] => 10580662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911853 [patent_doc_number] => 20050175611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Pharmaceutical preparation comprising an antibody against the EGF receptor' [patent_app_type] => utility [patent_app_number] => 10/996597 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4511 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175611.pdf [firstpage_image] =>[orig_patent_app_number] => 10996597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677774 [patent_doc_number] => 20060183130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Methods for assessing p19-Arf interactions with cMyc' [patent_app_type] => utility [patent_app_number] => 10/997763 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21703 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183130.pdf [firstpage_image] =>[orig_patent_app_number] => 10997763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010459 [patent_doc_number] => 20070280938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Peptides Derived from Natural Cytotoxicity Receptors and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 10/580428 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14524 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280938.pdf [firstpage_image] =>[orig_patent_app_number] => 10580428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966027 [patent_doc_number] => 20050232924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/993007 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19725 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232924.pdf [firstpage_image] =>[orig_patent_app_number] => 10993007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5027978 [patent_doc_number] => 20070269425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Anti-Idiotype Antibodies of the Human Monoclonal Antibody Sc-1, and Their Production and Use' [patent_app_type] => utility [patent_app_number] => 10/579147 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7498 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269425.pdf [firstpage_image] =>[orig_patent_app_number] => 10579147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348970 [patent_doc_number] => 07495086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'TWEAK receptor' [patent_app_type] => utility [patent_app_number] => 10/971250 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20900 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495086.pdf [firstpage_image] =>[orig_patent_app_number] => 10971250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110582 [patent_doc_number] => 20050208037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Thioredoxin increases redox-cycling of anticancer agents thereby sensitizes cancer cells to apoptosis' [patent_app_type] => utility [patent_app_number] => 10/970370 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 22379 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208037.pdf [firstpage_image] =>[orig_patent_app_number] => 10970370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813879 [patent_doc_number] => 20060084073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof' [patent_app_type] => utility [patent_app_number] => 10/970750 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38816 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084073.pdf [firstpage_image] =>[orig_patent_app_number] => 10970750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585992 [patent_doc_number] => 07439032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Methods to identify compounds useful for tumor sensitization to DNA damage' [patent_app_type] => utility [patent_app_number] => 10/968871 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20864 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439032.pdf [firstpage_image] =>[orig_patent_app_number] => 10968871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239713 [patent_doc_number] => 07592430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Antibodies to M-CSF' [patent_app_type] => utility [patent_app_number] => 10/938353 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 57 [patent_no_of_words] => 39495 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592430.pdf [firstpage_image] =>[orig_patent_app_number] => 10938353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120561 [patent_doc_number] => 20070142276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Protein involved in carcinoma' [patent_app_type] => utility [patent_app_number] => 10/569224 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16209 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142276.pdf [firstpage_image] =>[orig_patent_app_number] => 10569224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879721 [patent_doc_number] => 20080153104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Gene Overexpressed in Cancer' [patent_app_type] => utility [patent_app_number] => 10/568471 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 54902 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153104.pdf [firstpage_image] =>[orig_patent_app_number] => 10568471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345232 [patent_doc_number] => 07498420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Antibodies to c-Met' [patent_app_type] => utility [patent_app_number] => 10/910901 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 37352 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498420.pdf [firstpage_image] =>[orig_patent_app_number] => 10910901 [rel_patent_id] =>[rel_patent_doc_number] =>)